Literature DB >> 9160869

Changes in essential myosin light chain isoform expression provide a molecular basis for isometric force regulation in the failing human heart.

I Morano1, K Hädicke, H Haase, M Böhm, E Erdmann, M C Schaub.   

Abstract

We investigated the effects of the expression of myosin light chain (MLC) isoforms on the Ca2+ sensitivity of isometric force production of demembranated (skinned) fibers of papillary muscle from the left ventricle of three groups: patients with ischemic cardiomyopathy, patients with dilated cardiomyopathy (NYHA IV) and normal human hearts. Expression and phosphorylation of the phosphorylatable MLC isoforms (MLC-2) was equal within all three groups. However, 72% of the patients investigated in this study expressed the atrial essential MLC (ALC-1) in addition to the essential ventricular MLC (VLC-1) ranging between 2.4% and 10.3%. Using fibers from failing hearts, we observed a significant positive correlation between ALC-1 and Ca2+ sensitivity in that the higher the ALC-1 expression the higher the Ca2(+)-sensitivity: pCa50 (Ca2+ required for half-maximal force production) was 5.87 without ALC-1 and 6.08 with 10.3% ALC-1. Fibers from a normal heart (no ALC-1) revealed a pCa50 of 5.85. Isoform and phosphorylation patterns of tropomyosin and troponin I remained unchanged in the patients and normal hearts. Our results suggest that Ca2+ responsiveness and force development of the human heart is regulated by the expression of different MLC-1 isoforms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9160869     DOI: 10.1006/jmcc.1996.0353

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  30 in total

1.  A light, rather than a heavy solution for hard working hearts.

Authors:  F C Luft
Journal:  J Mol Med (Berl)       Date:  1999-09       Impact factor: 4.599

2.  Essential myosin light chain as a target for caspase-3 in failing myocardium.

Authors:  Alessandra Moretti; Hans-Jörg Weig; Thomas Ott; Melchior Seyfarth; Hans-Peter Holthoff; Diana Grewe; Angelika Gillitzer; Lorenz Bott-Flügel; Albert Schömig; Martin Ungerer; Karl-Ludwig Laugwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-19       Impact factor: 11.205

Review 3.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

Review 4.  Thick filament proteins and performance in human heart failure.

Authors:  Bradley M Palmer
Journal:  Heart Fail Rev       Date:  2005-09       Impact factor: 4.214

5.  Distinct sequences and post-translational modifications in cardiac atrial and ventricular myosin light chains revealed by top-down mass spectrometry.

Authors:  Zachery R Gregorich; Wenxuan Cai; Ziqing Lin; Albert J Chen; Ying Peng; Takushi Kohmoto; Ying Ge
Journal:  J Mol Cell Cardiol       Date:  2017-04-17       Impact factor: 5.000

6.  Integrated microRNA-mRNA analysis of coronary artery disease.

Authors:  Fei Chen; Xin Zhao; Juan Peng; LinPing Bo; Bing Fan; Duan Ma
Journal:  Mol Biol Rep       Date:  2014-06-10       Impact factor: 2.316

7.  MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy.

Authors:  Thomas S O'Leary; Julia Snyder; Sakthivel Sadayappan; Sharlene M Day; Michael J Previs
Journal:  J Mol Cell Cardiol       Date:  2018-12-11       Impact factor: 5.000

Review 8.  In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament.

Authors:  Samantha P Harris; Ross G Lyons; Kristina L Bezold
Journal:  Circ Res       Date:  2011-03-18       Impact factor: 17.367

9.  Frequency-dependent myofilament Ca2+ desensitization in failing rat myocardium.

Authors:  Regis R Lamberts; Nazha Hamdani; Tenoedj W Soekhoe; Nicky M Boontje; Ruud Zaremba; Lori A Walker; Pieter P de Tombe; Jolanda van der Velden; Ger J M Stienen
Journal:  J Physiol       Date:  2007-05-03       Impact factor: 5.182

Review 10.  Cardiovascular proteomics: past, present, and future.

Authors:  Melanie Y White; Jennifer E Van Eyk
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.